MAPT and type 2 diabetes mellitus: Potential mechanisms by which GLP-1RAs enhance cognition in T2DM patients include attenuation of oxidative stress, suppression of neuroinflammation, inhibition of apoptosis, reduction or prevention of Aβ accumulation, and mitigation of tau aggregation (Yaribeygi et al., 2021).